205 related articles for article (PubMed ID: 33548018)
1. Prognostic impact of incidentally detected hepatocellular carcinoma in explanted livers after living donor liver transplantation.
Rajakannu M; Vij M; Shaikh TMA; Rammohan A; Reddy MS; Rela M
Indian J Gastroenterol; 2021 Feb; 40(1):30-34. PubMed ID: 33548018
[TBL] [Abstract][Full Text] [Related]
2. Incidental Hepatocellular Carcinoma after Liver Transplantation: Clinicopathologic Features and Prognosis.
Ozdemir F; Ince V; Usta S; Carr BI; Bag HG; Akatli AN; Kahraman AS; Yilmaz S
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676654
[TBL] [Abstract][Full Text] [Related]
3. Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact.
Pérez P; Rodríguez-Perálvarez M; Guerrero L; González V; Sánchez R; Centeno M; Poyato A; Briceño J; Sánchez-Frías M; Montero JL; De la Mata M
PLoS One; 2017; 12(4):e0175010. PubMed ID: 28403219
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
[TBL] [Abstract][Full Text] [Related]
5. Incidental hepatocellular carcinoma: risk factors and long-term outcome after liver transplantation.
Senkerikova R; Frankova S; Sperl J; Oliverius M; Kieslichova E; Filipova H; Kautznerova D; Honsova E; Trunecka P; Spicak J
Transplant Proc; 2014 Jun; 46(5):1426-9. PubMed ID: 24935308
[TBL] [Abstract][Full Text] [Related]
6. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
Kulik LM; Fisher RA; Rodrigo DR; Brown RS; Freise CE; Shaked A; Everhart JE; Everson GT; Hong JC; Hayashi PH; Berg CL; Lok AS;
Am J Transplant; 2012 Nov; 12(11):2997-3007. PubMed ID: 22994906
[TBL] [Abstract][Full Text] [Related]
8. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
[TBL] [Abstract][Full Text] [Related]
9. The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma.
Chen J; Xu X; Wu J; Ling Q; Wang K; Wang W; Zhang M; Shen Y; Zhou L; Xie H; Zheng S
PLoS One; 2014; 9(3):e93128. PubMed ID: 24676010
[TBL] [Abstract][Full Text] [Related]
10. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
[TBL] [Abstract][Full Text] [Related]
12. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
13. Incidentally discovered hepatocellular carcinoma in explanted liver: clinical, histopathologic features and outcome.
Madaleno J; Alves R; Silva N; Calretas S; Tomé L; Ferrão J; Barros A; Diogo D; Cipriano A; Furtado E; Carvalho A
Transplant Proc; 2015 May; 47(4):1051-4. PubMed ID: 26036517
[TBL] [Abstract][Full Text] [Related]
14. Living-donor liver transplantation for hepatocellular carcinoma.
Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma.
Abdel-Wahab M; Sultan AM; Fathy OM; Salah T; Elshobary MM; Elghawalby NA; Yassen AM; Elsarraf WM; Elsaadany MF; Zalatah K
Hepatogastroenterology; 2013; 60(128):1847-53. PubMed ID: 24719918
[TBL] [Abstract][Full Text] [Related]
16. Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria.
Cho Y; Lee JH; Lee DH; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS
Oncotarget; 2017 Jul; 8(29):47555-47564. PubMed ID: 28548930
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of hepatocellular carcinoma after living donor liver transplantation: what is the current optimal approach to prevent recurrence?
Kaido T; Mori A; Ogura Y; Hata K; Yoshizawa A; Iida T; Uemoto S
World J Surg; 2011 Jun; 35(6):1355-9. PubMed ID: 21424873
[TBL] [Abstract][Full Text] [Related]
18. Outcome of Living-Donor Liver Transplant for Hepatocellular Carcinoma: 15-Year Single-Center Experience in Egypt.
Kamel R; Hatata Y; Hosny K; Nabil A; El-Deen Abd-Allah A; Mostafa A; Abdel-Aal A; Elganzoury MZ; Elmalt O; Marwan I; Hosny A
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):12-20. PubMed ID: 28301993
[TBL] [Abstract][Full Text] [Related]
19. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
Na GH; Kim EY; Hong TH; You YK; Kim DG
HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria).
Llovet JM; Pavel M; Rimola J; Diaz MA; Colmenero J; Saavedra-Perez D; Fondevila C; Ayuso C; Fuster J; Ginès P; Bruix J; Garcia-Valdecasas JC
Liver Transpl; 2018 Mar; 24(3):369-379. PubMed ID: 29140601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
